Macrogol, sodium chloride, sodium hydrogen carbonate, potassium chloride (*Molative Orange, Laxido Orange)
Macrogol, sodium chloride, sodium hydrogen carbonate, potassium chloride
Equity Pharmaceutical (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Equity Pharmaceutical (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| *Molative orange Each sachet contains MACROGOL 3350 13,125 g and SODIUM CHLORIDE 350,7 mg and SODIUM HYDROGEN CARBONATE 178,5 mg and POTASSIUM CHLORIDE 46,6 mg | Not listed | 48008648/11.5/0086 | Cancelled | Not determined | None |
| Laxido orange EACH SACHET CONTAINS: MACROGOL 3350 13,125 g SODIUM CHLORIDE 350,7 mg SODIUM HYDROGEN CARBONATE 178,5 mg POTASSIUM CHLORIDE 46,6 mg | 125 mlPowder for oral solution | 48008648/11.5/0086Approved 19 April 2022 | Cancelled | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.